Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Rida Chaudhry

Anesthesiology Saint Louis, MO Medical Doctor

NPI 1477048221 CMS profile 4763516

1 Barnes Jew Hosp Plz, Saint Louis, MO 63110

Open in the dashboard

General payments

$8,575

40 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rida Chaudhry of Saint Louis, MO is reported in the CMS Open Payments database as having received $8,575 across 40 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $24 1
2024 General $18 1
2023 General $3,341 22
2022 General $5,192 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rida Chaudhry
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Rida Chaudhry were reported at $24. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Rida Chaudhry Anesthesiology median Middle half National median
2019 $0 $72 $23–$151 $163
2020 $0 $36 $17–$120 $114
2021 $0 $49 $21–$135 $132
2022 $5,192 $52 $22–$144 $149
2023 $3,341 $53 $23–$143 $160
2024 $18 $55 $25–$150 $164
2025 $24 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $4,317 14 payments
  2. Abbott Laboratories $2,649 17 payments
  3. Boston Scientific Corporation $1,591 8 payments
  4. Nalu Medical, Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $4,209 19 payments
  2. Grant $3,000 1 payment
  3. Food and Beverage $1,366 20 payments
Products named General payments · program years 2022–2025
  1. SYNCHROMEDII $3,000 1 payment
  2. PROCLAIM Neuromodulation $2,440 12 payments
  3. INTELLIS ADAPTIVESTIM $1,317 13 payments
  4. General - Therapies $915 3 payments
  5. PROCLAIM Neuromodulation $124 1 payment
  6. OCTRODE Neuromodulation $45 2 payments
  7. OCTRODE Structural Heart $24 1 payment
  8. Nalu Neurostimulation System $18 1 payment
  9. PROCLAIM Neuromodulation $16 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

391

Median for Pain Management: 951

Drug cost

$4,664

Median for Pain Management: $26,034

Branded share of claims

3.6%

Median for Pain Management: 29.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 139 $1,588
Duloxetine Hcl Generic 62 $1,326
Pregabalin Generic 43 $743
Tizanidine Hcl Generic 49 $339
Oxycodone Hcl Generic 26 $254
Baclofen Generic 11 $162
Meloxicam Generic 25 $110
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 14 $77
Tramadol Hcl Generic 22 $64

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,732 Part D prescribers listed as Pain Management; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$51,709

Medicare's payments for the services billed

Medicare patients

382

Average age 73

Services billed

622

195 women, 187 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Ischemic heart disease 33%
Diabetes 30%
Chronic kidney disease 29%
Cancer 27%
Depression 25%
Atrial fibrillation 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

40 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record